Last reviewed · How we verify

NCT06948123: Nursing Theory

Myocardial Infarction

Completed NA Last updated 29 April 2025
What this trial tests

NA trial testing Educational intervention in Acute Coronary Syndromes in 106 participants. Completed in 15 December 2024.

Timeline
1 December 2023
Primary endpoint
15 June 2024
15 December 2024

Quick facts

Lead sponsorAydin Adnan Menderes University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposesupportive care
Enrollment106
Start date1 December 2023
Primary completion15 June 2024
Estimated completion15 December 2024
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Aydin Adnan Menderes University

Who can join

Adults 17 to 70, any sex, with Acute Coronary Syndromes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The effect of nursing approach based on Meleis's transition theory on cardiac quality of life and adaptation to disease in patients with acute myocardial infarction. This research was planned with the idea that the approach developed based on Meleis's Transition Theory could facilitate the illness-health transition process in patients, increase their healthy behavioral gains, increase the quality of care, reduce rehospitalizations, reduce the mortality rate due to MI, and contribute to the nursing literature.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Educational intervention

Trials testing the same drug.

Other recruiting trials for Acute Coronary Syndromes

Currently open trials in the same condition.

Other Aydin Adnan Menderes University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06948123.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing